Biopharma Partners II Lp Alta serves as Executive at CORCEPT THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Biopharma Partners II Lp Alta has executed 16 insider transactions totaling $9.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 7, 2014 involved exercising options for 1,848 shares valued at $0.
Biopharma Partners II Lp Alta currently holds 11,160 shares of CORCEPT THERAPEUTICS INC (CORT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Biopharma Partners II Lp Alta has been a net buyer of CORT stock. They have purchased $9.5M and sold $0 worth of shares.
Biopharma Partners II Lp Alta's most recent insider trade was on May 7, 2014, when they sold 1,848 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| May 7, 2014 | SCYX | $607 | Exercise | 3,033 | $0.20 | Discretionary |
| May 7, 2014 | SCYX | $35 | Exercise | 174 | $0.20 | Discretionary |
| May 7, 2014 | SCYX | $35 | Exercise | 174 | $0.20 | Discretionary |
| May 7, 2014 | SCYX | $8.7M | Purchase | 868,066 | $10.00 | Discretionary |
| May 7, 2014 | SCYX | $0 | Conversion | 69,476 | $N/A | Discretionary |
| May 7, 2014 | SCYX | $0 | Conversion | 50,239 | $N/A | Discretionary |
| May 7, 2014 | SCYX | $0 | Conversion | 161,238 | $N/A | Discretionary |
| May 7, 2014 | SCYX | $16.5K | Exercise | 82,454 | $0.20 | Discretionary |
| May 7, 2014 | SCYX | $910 | Exercise | 4,551 | $0.20 | Discretionary |
| May 7, 2014 | SCYX | $910 | Exercise | 4,551 | $0.20 | Discretionary |
| May 7, 2014 | SCYX | $319.3K | Purchase | 31,934 | $10.00 | Discretionary |
| May 7, 2014 | SCYX | $0 | Conversion | 2,642 | $N/A | Discretionary |
| Oct 16, 2009 | CORT | $465.4K | Purchase | 337,245 | $1.38 | Discretionary |
| Oct 16, 2009 | CORT | $17.1K | Purchase | 12,406 | $1.38 | Discretionary |